AU1870597A - Nucleic acid sequences of genes of the high mobility group proteins and uses thereof - Google Patents
Nucleic acid sequences of genes of the high mobility group proteins and uses thereofInfo
- Publication number
- AU1870597A AU1870597A AU18705/97A AU1870597A AU1870597A AU 1870597 A AU1870597 A AU 1870597A AU 18705/97 A AU18705/97 A AU 18705/97A AU 1870597 A AU1870597 A AU 1870597A AU 1870597 A AU1870597 A AU 1870597A
- Authority
- AU
- Australia
- Prior art keywords
- genes
- nucleic acid
- acid sequences
- high mobility
- mobility group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Genetics & Genomics (AREA)
- Pregnancy & Childbirth (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19548122 | 1995-12-21 | ||
DE19548122A DE19548122A1 (en) | 1995-12-21 | 1995-12-21 | Nucleic acid sequences of high mobility group protein genes and uses thereof |
PCT/DE1996/002494 WO1997023611A2 (en) | 1995-12-21 | 1996-12-20 | Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU71640/00A Division AU7164000A (en) | 1995-12-21 | 2000-11-16 | Nucleic acid sequences of genes of the high mobility group proteins and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1870597A true AU1870597A (en) | 1997-07-17 |
Family
ID=7781000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU18705/97A Abandoned AU1870597A (en) | 1995-12-21 | 1996-12-20 | Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0870024A2 (en) |
JP (3) | JP2000504933A (en) |
AU (1) | AU1870597A (en) |
CA (1) | CA2239682A1 (en) |
DE (1) | DE19548122A1 (en) |
NZ (1) | NZ504445A (en) |
WO (1) | WO1997023611A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19824230A1 (en) * | 1998-05-29 | 1999-12-02 | Starzinski Powitz Anna | New endometriosis-associated gene |
DE19904514A1 (en) * | 1999-02-04 | 2000-08-10 | Joern Bullerdiek | Antiviral agent, e.g. vaccine, antibody, agent that inhibits viral replication, transcription or translation, useful for preventing or treating tumors (or conditions which may become tumorous) associated with viral infections |
US7151082B2 (en) | 1999-02-11 | 2006-12-19 | The Feinstein Institute For Medical Research | Antagonists of HMG1 for treating inflammatory conditions |
US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
WO2001029080A1 (en) * | 1999-10-18 | 2001-04-26 | Shanghai Bio Road Gene Development Ltd. | A novel polypeptide - human high mobility group protein 13 and a polynucleotide encoding the same |
CN1300762A (en) * | 1999-12-23 | 2001-06-27 | 复旦大学 | Polypeptide-high-migration component protein family 11 and polynucleotide for codign this polypeptide |
US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
CA2470640A1 (en) * | 2001-12-19 | 2003-06-26 | Alcedo Biotech Gmbh | Use of hmgb proteins and nucleic acids that code therefor |
AU2003228099A1 (en) * | 2002-07-03 | 2004-01-23 | Centro Cardiologico Monzino S.P.A.-Irccs | Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
AU2004203732A1 (en) * | 2003-01-03 | 2004-07-22 | Alcedo Biotech Gmbh | Uses of HMGB, HMGN, HMGA proteins |
US7696169B2 (en) | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
EP1668035A2 (en) | 2003-09-11 | 2006-06-14 | Critical Therapeutics, Inc. | Monoclonal antibodies against hmgb1 |
AU2005333602B2 (en) | 2004-10-22 | 2012-04-12 | Medimmune, Llc | High affinity antibodies against HMGB1 and methods of use thereof |
US8129130B2 (en) | 2004-10-22 | 2012-03-06 | The Feinstein Institute For Medical Research | High affinity antibodies against HMGB1 and methods of use thereof |
US20080311122A1 (en) | 2005-11-28 | 2008-12-18 | Medimmune, Llc | Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5279941A (en) * | 1992-06-12 | 1994-01-18 | Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
EP0727487A1 (en) * | 1995-02-17 | 1996-08-21 | K.U. Leuven Research & Development | Multiple-tumor aberrant growth genes |
-
1995
- 1995-12-21 DE DE19548122A patent/DE19548122A1/en not_active Ceased
-
1996
- 1996-12-20 JP JP9523225A patent/JP2000504933A/en not_active Withdrawn
- 1996-12-20 AU AU18705/97A patent/AU1870597A/en not_active Abandoned
- 1996-12-20 EP EP96946114A patent/EP0870024A2/en not_active Withdrawn
- 1996-12-20 NZ NZ504445A patent/NZ504445A/en not_active IP Right Cessation
- 1996-12-20 WO PCT/DE1996/002494 patent/WO1997023611A2/en active Application Filing
- 1996-12-20 CA CA002239682A patent/CA2239682A1/en not_active Abandoned
-
2007
- 2007-06-05 JP JP2007149285A patent/JP2007312778A/en not_active Withdrawn
-
2009
- 2009-11-02 JP JP2009251811A patent/JP2010029207A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2007312778A (en) | 2007-12-06 |
WO1997023611A2 (en) | 1997-07-03 |
CA2239682A1 (en) | 1997-07-03 |
DE19548122A1 (en) | 1997-06-26 |
NZ504445A (en) | 2002-08-28 |
EP0870024A2 (en) | 1998-10-14 |
JP2010029207A (en) | 2010-02-12 |
WO1997023611A3 (en) | 1997-10-02 |
JP2000504933A (en) | 2000-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6042396A (en) | Amplification of nucleic acid sequences | |
AU7212494A (en) | Hybridization and sequencing of nucleic acids | |
AU6623896A (en) | Detection of nucleic acids and nucleic acid units | |
EP0742287B8 (en) | Modified nucleic acid probes | |
AU2816797A (en) | Method for determination of nucleic acid sequences and diagnostic applications thereof | |
AU2820595A (en) | Colon specific genes and proteins | |
EP0817798A4 (en) | Nucleotide and protein sequences of lats genes and methods based thereon | |
AU1870597A (en) | Nucleic acid sequences of genes of the high mobility group proteins and uses thereof | |
AU1450699A (en) | Methods of nucleic acid detection | |
AU2686200A (en) | Novel nucleic acid and amino acid sequences | |
AU6092394A (en) | Amplification of nucleic acid sequences | |
GB9516059D0 (en) | Novel genes and proteins | |
AU7378196A (en) | Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof | |
AU7136196A (en) | Pharmaceutical composition which is useful for the transfection of nucleic acids, and uses thereof | |
AU5847194A (en) | Novel entomopoxvirus genes, proteins and methods of use thereof | |
ZA961521B (en) | Isolated nucleic acid molecules which are members of the mage-xp family and uses thereof | |
AU1443095A (en) | Novel nucleic acid sequences isolated from glial cells | |
EP0910669A4 (en) | Isolated nucleic acid molecules which are members of the mage-b family and uses thereof | |
AU8505898A (en) | Nucleic acid compositions and methods of introducing nucleic acids into cells | |
AU4397797A (en) | Method of gene introduction | |
AU6833996A (en) | Identification of bases in nucleic acid sequences | |
AU5771894A (en) | Human cell adhesion molecule and nucleic acid sequences | |
AU7047794A (en) | Detection of nucleic acid sequences | |
AU6157996A (en) | Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus | |
PL320084A1 (en) | Nucleic acids of amino acid type |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |